Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Ongoing ClinicalTrials.gov study investigating the genetic causes and cancer predisposition in hereditary leiomyomatosis with renal cell car…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer [Phase 1, Phase 2]
Pfizer is conducting a Phase 1/2 study of PF-08634404 in adults with locally advanced or metastatic renal cell carcinoma; the trial is curre…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: CAIX PET/ CT Guided Radiation Therapy in CcRCC. [NA]
This entry reports an ongoing clinical trial evaluating CAIX PET/CT-guided radiation therapy for clear cell renal cell carcinoma, including …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
This clinical trial analyzes genetics of Birt-Hogg-Dubé syndrome and its link to kidney cancer. It is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers [Phase 2]
Phase 2 trial of AUR 109 in ovarian cancer, colorectal cancer, and renal cell carcinoma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) [Phase 3]
Phase 3 trial evaluating belzutifan and zanzalintinib in people with recurrent renal cell carcinoma after adjuvant therapy; the study is cur…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord [Phase 2]
This is a Phase 2 clinical trial update evaluating the combination of thermal ablation and spine stereotactic radiosurgery for spine metasta…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patient Preference for Subcutaneous vs. Intravenous Immune Therapy [Phase 2]
Phase 2 clinical trial update on patient preference for subcutaneous versus intravenous immune therapy; the study is currently recruiting ac…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain [Phase 2]
A completed Phase 2 trial evaluating sunitinib in patients with metastatic kidney cancer, including brain metastases. The update notes compl…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 1]
Phase 1 clinical trial evaluating nivolumab and ipilimumab with and without Camu Camu in metastatic renal cell carcinoma, including clear ce…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: ITIL-306 in Advanced Solid Tumors [Phase 1]
A Phase 1 trial of ITIL-306 in advanced solid tumors sponsored by Instil Bio has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Follow-up After Metastasectomy in Patients With Kidney Cancer [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating follow-up after metastasectomy in patients with renal cell carcinoma…
-
CLINICAL_TRIALS other · 2026-04-15Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating stereotactic body radiation therapy for oligometastatic renal cell carcinoma has been suspended.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Validation of RCC Predicting Model With Emulated-target Trial
This clinical trial update describes validation of a renal cell carcinoma prognostic model using an emulated-target trial approach, currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal Cancer
A terminated clinical trial assessed whether differences in sunitinib bioavailability influence treatment toxicity and efficacy in patients …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: "Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)" [NA]
The EMBARC trial assessing embolization before ablation for renal cell carcinoma (RCC) has completed.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma [Phase 2]
This update notes a Phase 2 clinical trial investigating the combination of tivozanib and nivolumab in advanced non-clear cell renal cell ca…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors [Phase 1]
KO-2806 is being studied in Phase 1 trials as a monotherapy and in combination regimens for advanced solid tumors, including HRAS-altered ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study [Phase 3]
PDIGREE is a Phase 3 trial evaluating nivolumab plus ipilimumab followed by nivolumab with or without cabozantinib in advanced renal cell ca…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial update investigates pembrolizumab in combination with aflibercept in patients with advanced cancers, including melanoma, col…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study [Phase 2]
Phase 2 trial exploring the addition of radium-223 dichloride to cabozantinib for advanced renal cell carcinoma with bone metastases (RadiCa…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
A completed Travera Inc trial evaluating TraveraRTGx and a tumor-cell biomarker intended to guide rapid therapy decisions across multiple ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours [Phase 1]
Phase 1 trial of GCAR1 CAR T-cell therapy for GPNMB-expressing solid tumors; study targets alveolar soft-part sarcoma, renal cell carcinoma,…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
Clinical trial evaluating cabozantinib in elderly patients with metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…